Literature DB >> 27488217

Physical Activity Correlates, Barriers, and Preferences for Women With Gynecological Cancer.

Laal Farrokhzadi1, Haryana M Dhillon, Chris Goumas, Jane M Young, Anne E Cust.   

Abstract

OBJECTIVE: Physical activity is associated with improved health outcomes for people with cancer. We aimed to identify physical activity correlates, barriers, and preferences among women with gynecological cancer. METHODS AND MATERIALS: A self-administered questionnaire was completed by 101 women diagnosed with gynecological cancer (mostly ovarian cancer [59%] and endometrial cancer [23%]) within the previous 2 years, at 2 major hospitals in Sydney, Australia. Physical activity was measured for the past 7 days. Thirteen potential barriers were scored on a 5-point scale. Associations with physical activity were assessed using Spearman correlations (rs) and multivariate logistic regression.
RESULTS: Factors associated with being sufficiently active (≥150 min/wk physical activity) were being in the follow-up phase of the cancer trajectory (odds ratio [OR], 7.0; 95% confidence interval [CI], 1.5 to 33.4 compared with other phases) and prediagnosis physical activity (OR, 4.6; 95% CI, 1.1 to 18.5 for the highest vs lowest tertile). The most common barriers were "too tired" and "not well enough," and both were associated with lower physical activity (rs, -0.20 and -0.22, respectively). The odds of having disease-specific barriers was higher for women with ovarian cancer (OR, 4.6; P = 0.04) and women receiving chemotherapy or radiation therapy (OR, 8.3; P = 0.008). "Lack of interest" (rs, -0.26) and "never been active" (rs, -0.23) were also inversely correlated with physical activity, although less common. Forty-three percent of women indicated that they were extremely or very interested to have a one-to-one session with an exercise physiologist. Participants' preferred time of starting a physical activity program was 3 to 6 months after treatment (26%) or during treatment (23%). Walking was the preferred type of physical activity.
CONCLUSIONS: Strategies to increase physical activity among women with gynecological cancer should include a focus on reducing disease-specific barriers and target women who have done little physical activity in the past or who are in the treatment phases of care.

Entities:  

Mesh:

Year:  2016        PMID: 27488217     DOI: 10.1097/IGC.0000000000000790

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema.

Authors:  Shirin M Shallwani; Anna Towers; Anne Newman; Shannon Salvador; Angela Yung; Lucy Gilbert; Walter H Gotlieb; Xing Zeng; Doneal Thomas
Journal:  Curr Oncol       Date:  2021-01-13       Impact factor: 3.677

Review 2.  Physical activity programming and counseling preferences among cancer survivors: a systematic review.

Authors:  Jaime N Wong; Edward McAuley; Linda Trinh
Journal:  Int J Behav Nutr Phys Act       Date:  2018-06-07       Impact factor: 6.457

3.  Factors influencing physical activity participation among people living with or beyond cancer: a systematic scoping review.

Authors:  Sarah Elshahat; Charlene Treanor; Michael Donnelly
Journal:  Int J Behav Nutr Phys Act       Date:  2021-04-06       Impact factor: 6.457

4.  ACCEPTANCE: protocol for a feasibility study of a multicomponent physical activity intervention following treatment for cervical cancer.

Authors:  Nessa Millet; Hilary J McDermott; Fehmidah Munir; Charlotte L Edwardson; Esther L Moss
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

5.  ENhAncing Lifestyle Behaviors in EndometriaL CancEr (ENABLE): A Pilot Randomized Controlled Trial.

Authors:  Lara Edbrooke; Pearly Khaw; Alison Freimund; Danielle Carpenter; Orla McNally; Lynette Joubert; Jenelle Loeliger; Anya Traill; Karla Gough; Linda Mileshkin; Linda Denehy
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.